Literature DB >> 7915152

Pharmacology and toxicology of Cremophor EL diluent.

R T Dorr1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7915152     DOI: 10.1177/10600280940280S503

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  41 in total

Review 1.  Role of formulation vehicles in taxane pharmacology.

Authors:  L van Zuylen; J Verweij; A Sparreboom
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

Review 2.  Oral delivery of taxanes.

Authors:  M M Malingré; J H Beijnen; J H Schellens
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

3.  Prieurianin Causes Weight Loss in Diet-Induced Obese Mice and Inhibits Adipogenesis in Cultured Preadipocytes.

Authors:  Ahmed Kablan; Rudel A Saunders; Maria Szkudlarek-Mikho; Andrew J B Chin; Raul M Bosio; Kazuyuki Fujii; Joseph Shapiro; Khew-Voon Chin
Journal:  J Diabetes Metab       Date:  2010-09-29

4.  Release modeling and comparison of nanoarchaeosomal, nanoliposomal and pegylated nanoliposomal carriers for paclitaxel.

Authors:  Fatemeh Movahedi; Hasan Ebrahimi Shahmabadi; Seyed Ebrahim Alavi; Maedeh Koohi Moftakhari Esfahani
Journal:  Tumour Biol       Date:  2014-05-28

5.  Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions.

Authors:  John K Jackson; Kevin C Skinner; Laurette Burgess; Tyler Sun; William L Hunter; Helen M Burt
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

6.  Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial.

Authors:  Ta-Chung Chao; Zyting Chu; Ling-Ming Tseng; Tzeon-Jye Chiou; Ruey-Kuen Hsieh; Wei-Shu Wang; Chueh-Chuan Yen; Muh-Hwa Yang; Liang-Tsai Hsiao; Jin-Hwang Liu; Po-Min Chen
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

7.  Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy.

Authors:  Sherly Quiles; Kevin P Raisch; Leisa L Sanford; James A Bonner; Ahmad Safavy
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

Review 8.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.

Authors:  Li Mu; Si-Shen Feng
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

10.  Cytotoxicity of liposomal Paclitaxel in breast cancer cell line mcf-7.

Authors:  Maedeh Koohi Moftakhari Esfahani; Seyed Ebrahim Alavi; Fatemeh Movahedi; Fatemeh Alavi; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.